Ruti Aga's Six-Year Ban: The Sanction Was Decided by a Forged Prescription, Not by the Injection

The prescription carried a clinic's name, a stamp, a doctor's signature. The Athletics Integrity Unit (AIU) could not find the clinic anywhere — no registration, no address, no doctor. The person who wrote it was a family member of the athlete, who explained that he had used "an old prescription pad from a former workplace." That workplace has since disowned the pad.

Since 10 September, Ruti Aga, a 32-year-old Ethiopian marathoner, is serving a six-year ban, announced in an AIU statement on Thursday. Headlines called it a steroid case. Here is the first correction: methylprednisolone is not an anabolic steroid. It is a glucocorticoid — class S9 on the WADA Prohibited List — and it is prohibited in-competition only, by injection, oral or rectal route. Class S1 is a different world, where the multi-year muscle-building cases live. This was a knee.

The facts arrive in this order. In March, Aga won a half marathon in China; an in-competition sample came back positive. A road race's testing window opens at 23:59 the day before the race, which is why an injection given days earlier still gets caught. The source gives no mark, no split, no field strength for that race. Any performance judgment here would mean inventing numbers. The one usable signal is that she won it — a World Athletics Label-tier elite field, the kind that carries in-competition testing.

Now the part nobody asked about. Because the substance sits in S9, Aga had a legitimate defence available: a therapeutic knee injection out-of-competition is entirely lawful, provided route, dose and timing are documented, and a TUE where required. That defence stands on paperwork — clinic records, a doctor's registration, the injection date. Instead, a forged prescription was produced. The career did not end because of the drug. It ended because of the document built to prove the drug.

The arithmetic is plain, and the arithmetic is the story: two years for the presence violation, four for tampering, six in total. The two-year figure tells us the panel treated the substance as specified and found no proven intent; the four-year figure tells us tampering was held fully culpable. The mitigation that did not arrive is no-significant-fault — and it did not arrive because the entire defence turned out to be fabricated. Backdating the ban to the 10 September provisional suspension is procedural housekeeping, not a discount; that time would have been served regardless.

Three independent verification failures sit inside the forgery. The clinic did not exist. The person who wrote the prescription held no medical registration. And the "old pad" was publicly disowned by the clinic it supposedly came from. Any one of those checks holding might have kept this out of tampering territory altogether. In place of medical support there was family — not a credentialed team physician, but the informal arrangement that is routine in remote training camps.

My notebook has opened with this column since 2026. At London Stadium that August, sixteen years old on a volunteer lanyard, I logged 412 interview windows — who was asked, who was skipped, how many seconds at the mic. Indian athletes got three windows all fortnight. In this case the count is not of questions but of their direction: nobody asked which route and which date the injection was given, though the whole case turned on it. What got asked was "steroid" — a substance this is not.

What survives of the career is the 2026 Tokyo Marathon title and three second places at World Marathon Majors. The violation is anchored to a March race, so earlier results are not automatically annulled absent a finding of prior use. The statement does not state the disqualification scope, though standard practice voids the result and prize money from the competition where the sample was taken. The race she won to make the news is the race on course to leave the record.

The forward arithmetic is brutal. Six years means a return at roughly 38 — the entire 2028 Olympic cycle gone. Ethiopian women's marathon depth is such that a 2:18–2:20 performer is not automatically selectable; a 38-year-old returning with a doping record is effectively unselectable. The sanction is six years on paper and a lifetime professionally.

The economics open here too. Between Majors, the Chinese and Asian label circuit is the most reliable appearance-fee income for East African marathoners — few races, good fees, a name that stays visible. That same tier is now the AIU's highest-yield testing ground. The fee economy and the testing economy are colliding in the same races, and for a runner with chronic knee pathology the glucocorticoid is the cheapest available tool for masking pain. Which is why document verification has stopped being a formality and become the axis of the case.

This is where I part company with the framing. The substance at the centre of a six-year ban has no established endurance benefit on the record. A knee injection plus a forged prescription ending a career, while anabolic cases on the same circuit draw four years, is a ratio that will be cited both as proof of AIU rigour and as proof of uneven enforcement against African road runners. The media blurred that ratio further by calling the substance a steroid, so the ordinary reader now files this under doping for gain rather than document fraud. The unanswered question points at the entourage: who helped construct the prescription, and was the agent or management ever investigated? The statement names only the family member. A 32-year-old does not build that apparatus alone; she served the sentence alone.

The next frontier is not the laboratory, it is the paperwork — TUE files, clinic registrations, injection dates and routes. That is where the cases will come from over the next two years, and where the fewest reporters are asking questions. What looks like a miracle is usually a spreadsheet someone finally balanced. The question is not who gets caught next; it is what the first question in the mixed zone will be about.